Literature DB >> 13045430

Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline; report of 120 cases.

D DONIACH.   

Abstract

Entities:  

Keywords:  HYPERTHYROIDISM/therapy; IMIDAZOLES/therapeutic use; THYROID ANTAGONISTS/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13045430     DOI： 10.1016/s0140-6736(53)92004-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Antithyroid substances. 3. Derivatives of 2-mercaptoglyoxalines.

Authors:  A LAWSON; C E SEARLE
Journal:  Biochem J       Date:  1955-02       Impact factor: 3.857

2.  Agranulocytosis from carbimazole.

Authors:  A BATTY SHAW
Journal:  Br Med J       Date:  1955-07-23

3.  The low toxicity of carbimazole; a survey of 1,046 patients.

Authors:  C D BURRELL; R FRASER; D DONIACH
Journal:  Br Med J       Date:  1956-06-23

4.  Fatal case of marrow aplasia after treatment with carbimazole; the effect of ACTH.

Authors:  J S RICHARDSON; I SARKANY; C D CAMPBELL
Journal:  Br Med J       Date:  1954-02-13

5.  Observations on 300 consecutive thyroidectomies.

Authors:  E MORRISON
Journal:  Ulster Med J       Date:  1955-05-01

6.  Carbimazole (neo-mercazole) in thyrotoxicosis--a review of sixty patients.

Authors:  M W BOYD
Journal:  Ulster Med J       Date:  1959-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.